SCHEMBL5585822

SCHEMBL5585822

O=C(N[C]1CCCCC1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
TP53 P04637 4/20 0.51
HTT P42858 3/20 0.51
GAA P10253 2/20 0.51
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51
RELA Q04206 2/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPT P10636 2/20 0.50
KCNK3 O14649 1/20 0.50
KCNK9 Q9NPC2 1/20 0.50
PKM P14618 1/20 0.50
PTPN1 P18031 1/20 0.50
KDM4E B2RXH2 3/20 0.49
ADCY1 Q08828 2/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27797782 0.94 RAB9A (0.57) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL5139150 0.78 NPC1 (0.46) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL10427470 0.76 NPC1 (0.47) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL3714874 0.73 FADS1 (0.50) NPC1RAB9ASMN1; SMN2GAAALDH1A1
Benzoic Acid Hydrazide SCHEMBL29222014 0.72 CYP3A4 (0.56) NPC1RAB9ASMN1; SMN2HTTGAA
SCHEMBL20621709 0.72 KDM4E (0.73) GAAALDH1A1MAPTKDM4ETDP1
SCHEMBL20621742 0.72 KDM4E (0.73) GAAALDH1A1MAPTKDM4ETDP1
SCHEMBL2387192 0.72 RAB9A (0.47) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL24202631 0.72 SIRT1 (0.83) NPC1RAB9ASMN1; SMN2HTTMEN1
SCHEMBL126415 0.72 PTPN1 (0.87) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1498411-B9 DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2013-12-04 EP disclosed
EP-1498411-B1 DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2013-01-16 EP disclosed
EP-1740584-A1 FUSED QUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-01-10 EP disclosed
US-7045526-B2 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-05-16 US disclosed
WO-2005105802-A1 FUSED QUINOLINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-10 WO disclosed
CN-1649831-A Diketohydrazine derivative compound and drug containing the same as active ingredient ONO PHARMACEUTICAL CO (JP) 2005-08-03 CN disclosed